These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 17088984)
1. CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion. Fu Y; Zagozdzon R; Avraham R; Avraham HK Int J Oncol; 2006 Dec; 29(6):1453-8. PubMed ID: 17088984 [TBL] [Abstract][Full Text] [Related]
2. Decreased CHK protein levels are associated with Src activation in colon cancer cells. Zhu S; Bjorge JD; Cheng HC; Fujita DJ Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522 [TBL] [Abstract][Full Text] [Related]
3. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration. McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569 [TBL] [Abstract][Full Text] [Related]
4. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion. Je DW; O YM; Ji YG; Cho Y; Lee DH Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells. Zagozdzon R; Bougeret C; Fu Y; Avraham HK Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987 [TBL] [Abstract][Full Text] [Related]
6. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets. Hirao A; Hamaguchi I; Suda T; Yamaguchi N EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. Hirao A; Huang XL; Suda T; Yamaguchi N J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Ito H; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE Surgery; 2003 Aug; 134(2):221-6. PubMed ID: 12947321 [TBL] [Abstract][Full Text] [Related]
10. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599 [TBL] [Abstract][Full Text] [Related]
11. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Guha S; Lunn JA; Santiskulvong C; Rozengurt E Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255 [TBL] [Abstract][Full Text] [Related]
12. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Lutz MP; Esser IB; Flossmann-Kast BB; Vogelmann R; Lührs H; Friess H; Büchler MW; Adler G Biochem Biophys Res Commun; 1998 Feb; 243(2):503-8. PubMed ID: 9480838 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta. Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543 [TBL] [Abstract][Full Text] [Related]
14. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration. Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285 [TBL] [Abstract][Full Text] [Related]
15. Functional analysis of Csk and CHK kinases in breast cancer cells. Bougeret C; Jiang S; Keydar I; Avraham H J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575 [TBL] [Abstract][Full Text] [Related]
16. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer. Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014 [TBL] [Abstract][Full Text] [Related]
17. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner. Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Karni R; Jove R; Levitzki A Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412 [TBL] [Abstract][Full Text] [Related]
19. EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2. Binker MG; Binker-Cosen AA; Richards D; Oliver B; Cosen-Binker LI Biochem Biophys Res Commun; 2009 Feb; 379(2):445-50. PubMed ID: 19116140 [TBL] [Abstract][Full Text] [Related]
20. Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Belsches-Jablonski AP; Biscardi JS; Peavy DR; Tice DA; Romney DA; Parsons SJ Oncogene; 2001 Mar; 20(12):1465-75. PubMed ID: 11313890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]